Inspections, Compliance, Enforcement, and Criminal Investigations

CPG Sec. 456.100 Non-Rx Drugs Anti-Obesity Preparations

POLICY:

We are not prepared to take regulatory action against the following class of products particularly those which have been on the market for a significant period of time:

Anti-obesity preparations containing phenylpropanolamine, methylcellulose, benzocaine, and related compounds, with or without vitamins offered only as an aid in reducing.

If the products contain other ingredients which would cause the drug to be dangerous to health when used as directed or if its labeling makes other claims we might wish to consider action. If you encounter such products which you believe warrant action, submit full labeling and formulation to the <> Division of Drug Labeling Compliance, *HFD-310* for advice before collecting samples for regulatory consideration.

*Material between asterisks is new or revised*
<> Indicates material has been deleted

Issued: 10/1/80
Revised: 5/22/87; 3/95

Page Last Updated: 03/20/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.